Search Within

Dermatology

Formats
  1. Journal Article (1294)
  2. Meeting Abstract (459)
  3. Book Section (152)
  4. Conference Paper (92)
  5. Research Letter (89)
  6. Review (88)
  7. Editorial (44)
  8. Correspondence (31)
  9. Guidelines (18)
  10. Book Whole (16)
  11. Miscellaneous (15)
Groups
  1. Department of Medicine (2298)
  2. Division of Subspecialty Medicine (2298)
  3. Dermatology Service (2266)
  4. Survivorship Research (1340)
  5. Melanoma Disease Management Team (679)
  6. Population Sciences Research Program (552)

More Groups

People
  1. Ashfaq Marghoob (543)
  2. Mario Lacouture (458)
  3. Allan Halpern (402)
  4. Stephen Dusza (281)
  5. Kishwer Nehal (280)
  6. Anthony Rossi (243)

More People

Years
  1. 2025 (59)
  2. 2024 (125)
  3. 2023 (118)
  4. 2022 (160)
  5. 2021 (140)
  6. 2020 (117)

More Years

Publications
  1. Journal of the American Academy of Dermatology (350)
  2. Journal of Investigative Dermatology (120)
  3. Journal of Clinical Oncology (117)
  4. JAMA Dermatology (94)
  5. Dermatologic Surgery (86)
  6. Archives of Dermatology (68)

More Publications

Publishers
  1. Mosby Elsevier (357)
  2. American Medical Association (170)
  3. Wiley Blackwell (164)
  4. Springer (155)
  5. Elsevier Science, Inc. (146)
  6. Lippincott Williams & Wilkins (138)

More Publishers

Results (2298)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Nail reactions to anticancer therapies
    Book Section

    Garshick, M. K.; Myskowski, P. L.
    In Rubin, A. I.; Jellinek, N. J.; Daniel, C. R. 3rd; Scher, R. K. (Eds.) Scher and Daniel's Nails: Diagnosis, Surgery, Therapy. 4th ed (2018)

    Fulltext@MSK | Save
  • T cell immunotherapies trigger innate immunity and aseptic inflammation leading to potent anti-tumor and off-targets effects
    Meeting Abstract

    Hirschhorn-Cymerman, D.; Ricca, J.; Gasmi, B.; De Henau, O.; Mangarin, L.; Budhu, S.; Li, Y.; Cortez, C.; Liu, C.; Zappasodi, R.; more...
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save
  • Durable responses observed with JAK inhibition in T-cell lymphomas
    Meeting Abstract

    Moskowitz, A. J.; Jacobsen, E.; Ruan, J.; Schatz, J. H.; Obadi, O.; Motylinski, K.; Jarjies, C.; Galasso, N.; Hancock, H.; Davey, T.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Rash in patients after T-cell-depleted peripheral blood stem cell transplantation: Eosinophilia and pruritus do not distinguish acute graft-versus-host disease from drug rash
    Meeting Abstract

    Klager, S. A.; Devlin, S. M.; Hannum, M.; Jakubowski, A. A.; Markova, A.
    Blood (2018)

    Fulltext@MSK | Save
  • HLA-a*0101 expression correlates with increased risk of severe cutaneous acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
    Meeting Abstract

    Fonseca, M.; Jakubowski, A. A.; Devlin, S. M.; Young, J. W.; Fatmi, S. A.; Maloy, M.; Giralt, S.; Ponce, D.; Markova, A.
    Blood (2018)

    Fulltext@MSK | Save
  • Podiatric adverse events and foot care in cancer patients and survivors: Awareness, education, and literature review
    Journal Article

    Lacouture, M. E.; Kopsky, D. J.; Lilker, R.; Damstra, F.; van der Linden, M. H. M.; Freites-Martinez, A.; Nagel, M. P. M.
    Journal of the American Podiatric Medical Association (2018)

    Fulltext@MSK | Save
  • Lymphomatoid papulosis in a 37-year-old woman with relapsing multiple sclerosis treated with dimethyl fumarate
    Meeting Abstract

    George, I.; Kheterpal, M.; Miller, A.
    Neurology (2018)

    Fulltext@MSK | Save
  • Low-grade cutaneous B-cell lymphoma in African American patients
    Journal Article

    Geller, S.; Pulitzer, M.; Myskowski, P. L.; Kheterpal, M.
    Journal of Drugs in Dermatology (2018)

    Fulltext@MSK | Save
  • Reconstruction of a combined nose and cheek defect
    Journal Article

    Qi, Q.; Hibler, B. P.; Connolly, K. L.; Rossi, A. M.
    Dermatologic Surgery (2018)

    Fulltext@MSK | Save
  • Regorafenib dose optimization study (ReDOS): Randomized phase II trial to evaluate dosing strategies for regorafenib in refractory metastatic colorectal cancer (mCRC): An ACCRU Network study
    Meeting Abstract

    Bekaii-Saab, T. S.; Ou, F. S.; Anderson, D. M.; Ahn, D. H.; Boland, P. M.; Ciombor, K. K.; Jacobs, N. L.; Desnoyers, R. J.; Cleary, J. M.; Meyers, J. P.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save